Scientists are developing new treatments for ulcerative colitis (UC). There is ongoing scientific research into stem cell therapy for UC. Despite such developments, it remains an incurable condition. UC is an inflammatory condition that affects an individual’s colon. Its primary symptom is frequent...
Oshi Healthwon this week’s Big Raise with a $60 million Series C.Oshi is a virtual-first gastrointestinal care clinic integrating evidence-based medical care and behavioral health support for patients with Crohn’s Disease, irritable bowel syndrome (IBS) and ulcerative colitis. Funding was led ...
… news alerts and subscriptions latest content eli lilly appoints new chief ai officer october 17, 2024 flypharma europe, vienna – 23-24 october 2024 conference october 14, 2024 ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcera...
News & Views11 Oct 2023Nature Medicine Volume: 29, P: 2420-2421 Upadacitinib therapy for Crohn’s disease Eleni Kotsiliti Research Highlights27 Jun 2023Nature Reviews Gastroenterology & Hepatology Volume: 20, P: 483 Etrasimod for ulcerative colitis: evaluating phase III results ...
Network pharmacological prediction of the mechanism of action of Shen-Zhu-Lian-Bai Decoction in the treatment of ulcerative colitis Li Zhu Jinghua Liang ResearchOpen Access20 Jun 2024 Scientific Reports Volume: 14, P: 14183 Pharmacological modulation of developmental and synaptic phenotypes in human...
severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohns disease, which can affect the entire gastrointestinal tract, but is most common in the colon and terminal ileum; and ulcerative colitis, which is a mucosal inflammation involving the rectum and colon...
Find all the latest on chronic pain at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Johnson & Johnson Secures FDA Approval for Tremfya as Ulcerative Colitis Treatment Sep. 12 MT J&J: FDA approves Tremfya for ulcerative colitis Sep. 12 CF J&J CFO Sees Value in Tech Partnerships Sep. 12 MT How J&J's CFO Keeps His Footing on the 'Paten...
But first, lets back up for a moment and get some context on this whole IGF-1 thing and why it’s so relevant. As you might’ve seen in some of the news reports, the lead researcher of this study was Valter Longo—the director of the University of Southern California’s Longevity Ins...
Find all the latest on chronic diseases at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.